SBDR - SOCIETY FOR BIOMEDICAL DIABETES RESEARCH
Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations